Companies: 49,246 Total Market Cap: 132391015460924.41

Fisher & Paykel Healthcare Corporation Limited

NZE-FPH
Healthcare Medical Instruments & Supplies
Rank #1561
Market Cap 12.24 B
Volume 564,796
Price 20.88
Change (%) 1.64%
Country or region New Zealand New Zealand

Fisher & Paykel Healthcare Corporation Limited's latest marketcap:

12.24 B

As of 05/20/2025, Fisher & Paykel Healthcare Corporation Limited's market capitalization has reached $12.24 B. According to our data, Fisher & Paykel Healthcare Corporation Limited is the 1561th most valuable company globally by market capitalization. Market capitalization, commonly referred to as market cap, represents the total market value of all outstanding shares of a publicly traded company and is often used as a measure of company value.

Market Cap 12.24 B
Revenue (ttm) 1.12 B
Net Income (ttm) 105.56 M
Shares Out 586.26 M
EPS (ttm) 0.18
Forward PE 52.96
Ex-Dividend Date 12/05/2024
Earnings Date 05/27/2025
Market Cap Chart
Data Updated: 05/20/2025

Fisher & Paykel Healthcare Corporation Limited's yearly market capitalization.

Fisher & Paykel Healthcare Corporation Limited has seen its market value grow from NZ$18.99 B to NZ$20.70 B since 2020, representing a total increase of 9.00% and an annual compound growth rate (CAGR) of 1.98%.
Date Market Cap Change (%)
05/20/2025 NZ$20.70 B -6.49%
12/31/2024 NZ$22.51 B 63.32%
12/29/2023 NZ$13.78 B 5.28%
12/30/2022 NZ$13.09 B -30.76%
12/31/2021 NZ$18.91 B -0.45%
12/31/2020 NZ$18.99 B

Company Profile

About Fisher & Paykel Healthcare Corporation Limited

Fisher & Paykel Healthcare Corporation Limited, together with its subsidiaries, designs, manufactures, markets, and sells medical device products and systems globally, with operations in North America, Europe, the Asia Pacific, and other international markets.

Product Offerings

  • Acute & Chronic Respiratory Care: Solutions for both hospital and home use, including treatments for obstructive sleep apnea (OSA).
  • Adult Respiratory Products: Features Optiflow nasal high flow therapy, invasive ventilation, and noninvasive ventilation.
  • Infant Respiratory Products: Includes resuscitation, invasive ventilation, CPAP therapy, and nasal high flow therapy.
  • Hospital Products: Humidification systems, breathing circuits, masks, nasal cannulas, surgical accessories, and interfaces.
  • Homecare Products: CPAP devices, masks, humidifiers, and software for data management.

Company Background

Founded in 1934, Fisher & Paykel Healthcare Corporation Limited is headquartered in Auckland, New Zealand.

Frequently Asked Questions

As of 05/20/2025, Fisher & Paykel Healthcare Corporation Limited (including the parent company, if applicable) has an estimated market capitalization of $12.24 B USD. This figure represents the total market value of its outstanding shares, including different share classes. Please note that market capitalization fluctuates based on market conditions, and the actual valuation may differ from the latest estimate.

Fisher & Paykel Healthcare Corporation Limited global market capitalization ranking is approximately 1561 as of 05/20/2025. This ranking is relative to all publicly traded companies worldwide and can fluctuate based on market dynamics and the performance of other companies. You can refer to our Global companies market cap ranking for the most up-to-date ranking.

Stock Detail

Country or region New Zealand
Founded 1934
IPO Date n/a
Employees 7,031
CEO Lewis Gradon
Sector Healthcare
Industry Medical Instruments & Supplies
Address 15 Maurice Paykel Place
Auckland, 2013
New Zealand
Website https://www.fphcare.com
People Also Watch
ISRG
554.54 1.64%
EPA-EL
294.89 1.64%
BDX
176.42 1.64%
Alcon
87.76 1.64%